ATE272403T1 - Therapeutisches mittel zur behandlung von dermatitis - Google Patents

Therapeutisches mittel zur behandlung von dermatitis

Info

Publication number
ATE272403T1
ATE272403T1 AT01109332T AT01109332T ATE272403T1 AT E272403 T1 ATE272403 T1 AT E272403T1 AT 01109332 T AT01109332 T AT 01109332T AT 01109332 T AT01109332 T AT 01109332T AT E272403 T1 ATE272403 T1 AT E272403T1
Authority
AT
Austria
Prior art keywords
therapeutic agent
dermatitis
reaction
atopic dermatitis
agent
Prior art date
Application number
AT01109332T
Other languages
English (en)
Inventor
Haruo Yoshii
Akihiro Fujita
Original Assignee
Nippon Zoki Pharmaceutical Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nippon Zoki Pharmaceutical Co filed Critical Nippon Zoki Pharmaceutical Co
Application granted granted Critical
Publication of ATE272403T1 publication Critical patent/ATE272403T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Dermatology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT01109332T 2000-04-13 2001-04-12 Therapeutisches mittel zur behandlung von dermatitis ATE272403T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP2000111809 2000-04-13

Publications (1)

Publication Number Publication Date
ATE272403T1 true ATE272403T1 (de) 2004-08-15

Family

ID=18624080

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01109332T ATE272403T1 (de) 2000-04-13 2001-04-12 Therapeutisches mittel zur behandlung von dermatitis

Country Status (10)

Country Link
US (1) US6440978B2 (de)
EP (1) EP1145716B1 (de)
KR (1) KR20010098583A (de)
CN (1) CN1192776C (de)
AT (1) ATE272403T1 (de)
AU (1) AU775851B2 (de)
CA (1) CA2344182A1 (de)
DE (1) DE60104589T2 (de)
ES (1) ES2223676T3 (de)
TW (1) TWI243055B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030175314A1 (en) * 2001-11-19 2003-09-18 Didriksen Erik Johannes Pharmaceutical composition for dermal application
FR2832711B1 (fr) 2001-11-26 2004-01-30 Warner Lambert Co Derives de triazolo [4,3-a] pyrido [2,3-d] pyrimidin-5-ones, compositions les contenant, procede de preparation et utilisation
TW200800997A (en) * 2006-03-22 2008-01-01 Astrazeneca Ab Chemical compounds
SA08280783B1 (ar) * 2007-01-11 2011-04-24 استرازينيكا ايه بي مشتقات بيريدوبيريميدين كمثبطات pde4
TWI483729B (zh) 2010-03-11 2015-05-11 Nippon Zoki Pharmaceutical Co 慢性前列腺炎、間質性膀胱炎及／或排尿障礙之改善或治療劑
KR101894754B1 (ko) 2010-10-14 2018-09-04 니폰 조키 세야쿠 가부시키가이샤 연골세포의 콜라겐 및 프로테오글리칸의 합성 촉진 방법

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB989048A (en) 1962-08-02 1965-04-14 Mead Johnson & Co Pyrido[2,3-d]pyrimidines
US3235554A (en) 1963-11-12 1966-02-15 Searle & Co 7-amino-1-methyl-2, 4-dioxo-1, 2, 3, 4, 5, 6-hexahydropyrido[2, 3-d]-pyrimidine and related compounds
US3272816A (en) 1965-04-28 1966-09-13 Searle & Co 7-amino-2, 4-dioxo-1, 2, 3, 4-tetrahydropyrido[2, 3-d]pyrimidines
US3275634A (en) 1965-09-02 1966-09-27 Searle & Co 7-hydroxy-2, 4-dioxo-1, 2, 3, 4, 5, 6-hexahydropyrido[2, 3-d]pyrimidines
LU65139A1 (de) 1972-04-07 1973-10-22
GB1401549A (en) 1972-07-07 1975-07-16 Hisamitsu Pharmaceutical Co Pyrido-2,3-d-pyrimidine-2,4-1h,3h- diones and methods of preparing them
JPS60226882A (ja) 1984-04-24 1985-11-12 Nippon Zoki Pharmaceut Co Ltd 新規ピリミドピリミジン誘導体
US4808587A (en) 1986-04-16 1989-02-28 Nippon Zoki Pharmaceutical Co., Ltd. 5-substituted pyrido[2,3-d]pyrimidine-2,4-diones
DE3770095D1 (de) 1986-08-21 1991-06-20 Pfizer Chinazolindione und pyridopyrimidindione.
DE4035479A1 (de) 1990-11-08 1992-05-14 Basf Ag Substituierte pyrido (2,3-d)pyrimidin-2,4(1h,3h)-dione
US5264437A (en) 1992-03-20 1993-11-23 Syntex (U.S.A.) Inc. Optionally substituted pyrido[2,3-d]pyridine-2,4(1H,3H)-diones and pyrido[2,]pyrimidine-2(1H,3H)-ones
JP3113440B2 (ja) 1992-03-25 2000-11-27 日本臓器製薬株式会社 ピリジニウム誘導体
HUT74170A (en) * 1993-07-06 1996-11-28 Pfizer Bicyclic tetrahydro pyrazolopyridines
US5776942A (en) 1994-06-17 1998-07-07 Nippon Zoki Pharmaceutical Co., Ltd. Bronchodilating pyrido 2,3-d!pyrimidine derivatives
JP3242792B2 (ja) 1994-08-05 2001-12-25 日本臓器製薬株式会社 ナフチリジニウム誘導体
JP2000119272A (ja) * 1998-10-15 2000-04-25 Nippon Zoki Pharmaceut Co Ltd 新規７−アミノピリド〔２，３−ｄ〕ピリミジン誘導体

Also Published As

Publication number Publication date
CN1321465A (zh) 2001-11-14
US6440978B2 (en) 2002-08-27
TWI243055B (en) 2005-11-11
DE60104589T2 (de) 2005-07-28
KR20010098583A (ko) 2001-11-08
EP1145716B1 (de) 2004-08-04
ES2223676T3 (es) 2005-03-01
DE60104589D1 (de) 2004-09-09
CA2344182A1 (en) 2001-10-13
CN1192776C (zh) 2005-03-16
AU3511601A (en) 2001-10-18
EP1145716A3 (de) 2002-06-12
EP1145716A2 (de) 2001-10-17
US20010056097A1 (en) 2001-12-27
AU775851B2 (en) 2004-08-19

Similar Documents

Publication Publication Date Title
GB0318447D0 (en) Therapeutic agents
TW200614983A (en) 5-substituted-2-phenylamino benzamides as MEK inhibitors
GB0225475D0 (en) Therapeutic agents
ATE381537T1 (de) Formanilid-derivative als beta2-adrenorezeptor- agonisten
BR0312729A (pt) Novos derivados de indol-3-enxofre
EA200300776A1 (ru) Производные фенэтаноламина для лечения респираторных заболеваний
BRPI0409227B8 (pt) "composto, composição farmacêutica, uso de um composto e processo para a preparação de um composto de fórmula (i)"
DE60316779D1 (de) Thiadiazolylpiperazinderivate geeignet für die behandlung bzw. prävention von schmerzen
WO2001039759A3 (en) Sulfonic acid or sulfonylamino n-(heteroaralkyl)-azaheterocyclylamide compounds
BRPI0418074B8 (pt) derivado de amida, composição farmacêutica, inibidor da tirosina cinase bcr-abl e agentes terapêuticos
BR0314754A (pt) Agente terapêutico ou profilático para a frequência urinária ou a incontinência urinária ou um seu sal de adição de ácido farmaceuticamente aceitável, método para terapia ou profilaxia para frequência urinária, urgência urinária ou incontinência urinária, uso de um derivado de morfina tendo um grupo heterocìclico contendo nitrogênio ou de um seu sal de adição de ácido farmaceuticamente aceitável, derivado de morfina ou um seu sal de adição de ácido farmaceuticamente aceitável, produto farmacêutico, e, composição farmacêutica
ATE366107T1 (de) Verwendung von sulfodehydroabietinsäure zur behandlung entzündlicher darmerkrankungen
DE60031686D1 (de) Pyrazinone, diese verbindungen enthaltende zusammenstellungen
BR0311363A (pt) Formulação farmacêutica de liberação imediata, uso da mesma, e, método para tratar um distúrbio cardiovascular em um paciente
ATE272403T1 (de) Therapeutisches mittel zur behandlung von dermatitis
HUT77135A (hu) Eljárás I típusú allergiás betegségek megelőzésére és kezelésére alkalmazható gyógyszerkészítmények előállítására
DK1174131T3 (da) Anvendelse af et middel til forbedring af astrocytfunktion til behandling af Parkinsons sygdom
EP1325748A4 (de) Prophylaktische oder therapeutische arzneimittel gegen krebs enthaltend cyanidinverbindungen als wirkstoff
PT1290012E (pt) Derivados amida do acido 2-amino-3-hidroxi-4-tert-leucil-amino-5-fenil-pentanoico
MX2023000437A (es) Derivado de bencisoxazol.
SG146685A1 (en) Dihydroporphine derivatives, processes for their preparation, and pharmaceutical compositions containing them
EP1291349A4 (de) Malto-oligosaccharide und deren verwendung
GB0229022D0 (en) Organic Compounds
HUP0402072A2 (hu) 1,3-Oxazol- vagy -tiazolgyűrűt tartalmazó glicinszármazékok és ezeket a vegyületeket hatóanyagként tartalmazó szerek
DE60315597D1 (de) Haloacetamidobenzoesäure derivate und deren verwendung zur behandlung von parasitären erkrankungen

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties